SUN PHARMACEUTICAL INDUSTRIES INC recalls Clindamycin Phosphate USP
- Recalling company
- SUN PHARMACEUTICAL INDUSTRIES INC
- Product
- Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4
- Reason
- Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
- Classification
- Class III – not likely to cause adverse health consequences
- Recall date
- Nov 26, 2025
- Reported
- Jan 21, 2026
- Distribution
- Nationwide in the USA.
- Status
- Ongoing
- Lot / codes
- Lot#: AD30154, AD31143, AD31145, Exp 11/30/2025
- Company location
- Princeton, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0257-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0257-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.